Showing results (61-70 of 189) with videos related to
Sort By:
Pageof 19
Molecular Therapy. Nucleic Acids|December 5, 2018
Overcoming the Undesirable CRISPR-Cas9 Expression in Gene CorrectionEmily Xia, Rongqi Duan, Fushan Shi, et al.Cancer Research|July 10, 2007
Elevated frequencies of self-reactive CD8+ T cells following immunization with a xenoantigen are due to the presence of a heteroclitic CD4+ T-cell helper epitopeKorosh Kianizad, Laura A Marshall, Natalie Grinshtein, et al.Cancer Immunology, Immunotherapy : CII|August 15, 2009
Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cellsBo Li, Zhang Lei, Brain D Lichty, et al.Oncoimmunology|October 2, 2013
Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8<sup>+</sup> T-cell responses to anticancer vaccinesByram W Bridle, Derek Clouthier, Liang Zhang, et al.Journal of Virology|January 20, 2012
Induction of immunological tolerance to adenoviral vectors by using a novel dendritic cell-based strategyRahul Kushwah, Jordan R Oliver, Rongqi Duan, et al.Plos One|April 12, 2016
High Physiological Concentrations of Progesterone Reverse Estradiol-Mediated Changes in Differentiation and Functions of Bone Marrow Derived Dendritic CellsFangming Xiu, Varun C Anipindi, Philip V Nguyen, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2005
Recombinant adenovirus vaccines can successfully elicit CD8+ T cell immunity under conditions of extreme leukopeniaNatalie Grinshtein, Teng-Chih Yang, Robin Parsons, et al.Vaccine|March 17, 2018
Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancerMatthew J Atherton, Kyle B Stephenson, Jake K Nikota, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirusByram W Bridle, Jeanette E Boudreau, Brian D Lichty, et al.Current Gene Therapy|October 28, 2005
Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccinesZhou Xing, Michael Santosuosso, Sarah McCormick, et al.Pageof 19